22nd Century Group (XXII)

[admin]

Not anywhere near complete, but

1. The end of Sabby (their former financing partner) selling
2. The granting of patents
3. The conclusion of other deals (in a June PR they suggested other licensing deals in the works)
4. Sales figures from the Benelux
5. Granting of the second $7M payment from BAT
6. Conversion of the BAT research license into a royalty license
7. Progress on a multiple US front (FDA trials and regulations)

Or just the simple recognition by more investors that XXII (a $50M company) has unique IP, in a multi-billion dollar market that has just found validation the second biggest company in the industry.